Most recent by Mark Leiser
Alert-based patient-reported outcome monitoring improves breast cancer symptom control
SAN ANTONIO — Use of alerts triggered by patient-reported outcome monitoring improved symptom control for patients with advanced breast cancer, according to results of the randomized PRO B trial.
Adding cisplatin to radiation fails to extend survival in intermediate-risk cervical cancer
The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, early-stage cervical cancer who underwent radical hysterectomy, according to randomized phase 3 study results.
VIDEO: CancerX Accelerator provides ‘inside-out view’ of how health systems make decisions
An evidence-based AI platform aims to transform cancer care by providing comprehensive solutions for oncology patient management.
VIDEO: Company aims to bring ‘clarity to the complexity’ of medical decision-making
A digital health company aims to provide timely and personalized treatment plans for every person with cancer, as well as their physicians.
VIDEO: CancerX offers ‘unparalleled opportunity’ to collaborate with health care leaders
A precision trial matching platform is designed to help people with cancer quickly identify and access appropriate treatment options.
VIDEO: AI has ‘truly transformational potential’ to detect cancer at most treatable stage
An AI-based cancer prediction system is designed to ensure a higher percentage of cancers are diagnosed at earlier, more treatable stages.
PD-1 blockade induces response in surgically resectable endometrial cancer
PD-1 blockade conferred benefit to certain women with surgically resectable endometrial cancer, findings presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.
Two-drug regimen active in advanced endometrial cancer
A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.
Discussion about NIH research funding cuts requires 'data, time and careful evaluation'
NIH’s plan to cut what it pays universities and other entities for indirect costs associated with scientific research would create “extremely challenging” short- and long-term impacts, according to a renowned data scientist and researcher.
Research community braces for 'profoundly negative impact' of NIH cuts
NIH’s decision to cut what it pays universities and other entities for indirect costs associated with scientific research would have immediate and far-reaching consequences, according to many academic institutions and professional societies.